Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02266277 · ClinicalTrials.gov registry record · NA
System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 30,000
- Enrollment target
NCT02266277: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT02266277 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 30,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2038% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02266277, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 30,000 participants
- Enrollment target
Study Summary
The goal of this research study is to improve rates of appropriate influenza and pneumococcal vaccination among adults who receive care at a large multi-specialty group practice in central Massachusetts. The investigators plan to conduct a non-blinded randomized controlled trial during flu season 2014-2015 (Cycle 1). A total of 20,000 e-portal users and 10,000 non e-portal users who are identified in the Reliant Medical Group (RMG) Electronic Health Record (EHR) as not being up to date on their influenza vaccines will be randomized. E-portal users will be randomized to receive: * Arm 1: E-portal message with Interactive Voice Recognition (IVR) call * Arm 2: E-portal message with no IVR call * Arm 3: No e-portal message with IVR call OR * Arm 4: No e-portal message with no IVR call (Control, e-portal users) Non e-portal users will be randomized to receive either: * Arm 5: IVR call OR * Arm 6: no IVR call (Control, non e-portal users)
Primary Outcome
To determine the impact of our interventions on influenza vaccine completion for the 2014-15 influenza season, we calculated frequencies and performed intention-to-treat bivariate analyses of randomized patients (30,000 patients), assessing whether randomization group was associated vaccine completion. Due to differential rates of vaccination at baseline between portal users and non-users, analyses in these groups were conducted separately. We then performed multivariate logistic regression anal
Interventions
- OTHER Arm 1: E-portal message with IVR call
- OTHER Arm 2: E-portal message with no IVR call
- OTHER Arm 3: No e-portal message with IVR call
- OTHER Arm 5: IVR call
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02266277 record still lists
NCT02266277 is an interventional study that assigns participants to a tested intervention. Its 30,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2038% higher).
The record links to 0 conditions, and to 4 interventions - of which Arm 1: E-portal message with IVR call is the first listed.
NCT02266277 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02266277 about?
NCT02266277 is a clinical study titled "System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts". The goal of this research study is to improve rates of appropriate influenza and pneumococcal vaccination among adults who receive care at a large multi-specialty group practice in central Massachusetts. The investigators plan to conduct a non-blinded randomized controlled trial during flu season 2...
What is the current status of trial NCT02266277?
This trial is currently completed. It is a NA study. The enrollment target is 30,000 participants. The study started on 2014-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02266277?
The interventions under investigation include: Arm 1: E-portal message with IVR call (OTHER), Arm 2: E-portal message with no IVR call (OTHER), Arm 3: No e-portal message with IVR call (OTHER), Arm 5: IVR call (OTHER).
Who is sponsoring clinical trial NCT02266277?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02266277's enrollment target sits among peer trials
30,000 8th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia